Back to search

Article

Neutralizing antibodies to SARS-CoV-2 Omicron variant after 3 <sup>rd</sup> mRNA vaccination in health care workers and elderly subjects and response to a single dose in previously infected adults

2021-12-24

Abstract excerpt

The emergence of SARS-CoV-2 Omicron variant (B.1.1.529) with major spike protein mutations has raised concern over potential neutralization escape and breakthrough infections among vaccinated and previously SARS-CoV-2 infected subjects. We measured cross-protective antibodies against variants in health care workers (HCW, n=20) and nursing home residents (n=9) from samples collected 1-2 months following the booster...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
7d279cdb-79ce-5709-a9c5-1dce4367055f
DOI
10.1101/2021.12.22.21268273
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Neutralizing antibodies to SARS-CoV-2 Omicron variant after 3 <sup>rd</sup> mRNA vaccination in health care workers and elderly subjects and response to a single dose in previously infected adultsDOI 10.1101/2021.12.22.21268273
SARS-CoV-2 Omicron Variant Infection of Individuals with High Titer Neutralizing Antibodies Post-3<sup>rd</sup> mRNA Vaccine DoseSemantic proximity
SARS-CoV-2 Omicron neutralization by therapeutic antibodies, convalescent sera, and post-mRNA vaccine boosterSemantic proximity
mRNA booster immunization elicits potent neutralizing serum activity against the SARS-CoV-2 Omicron variantSemantic proximity
mRNA-Based COVID-19 Vaccine Boosters Induce Neutralizing Immunity Against SARS-CoV-2 Omicron VariantSemantic proximity
Plasma neutralization properties of the SARS-CoV-2 Omicron variantSemantic proximity
Divergent SARS CoV-2 Omicron-specific T- and B-cell responses in COVID-19 vaccine recipientsSemantic proximity
SARS‐CoV‐2 Omicron BA.1 variant breakthrough infections in nursing home residents after an homologous third dose of the Comirnaty® COVID‐19 vaccine: Looking for correlates of protectionSemantic proximity
mRNA booster immunization elicits potent neutralizing serum activity against the SARS-CoV-2 Omicron variantSemantic proximity
Four doses of the inactivated SARS-CoV-2 vaccine redistribute humoral immune responses away from the Receptor Binding DomainSemantic proximity
Increased resistance of SARS-CoV-2 Omicron Variant to Neutralization by Vaccine-Elicited and Therapeutic AntibodiesSemantic proximity
Safety and immunogenicity of Pfizer/BioNTech SARS-CoV-2 mRNA third booster vaccine against SARS-CoV-2 Omicron variant in Japanese healthcare workersSemantic proximity
Antibody avidity and neutralizing response against SARS-CoV-2 Omicron variant after infection or vaccinationSemantic proximity
Select a neighboring publication to make it the new centre.